Melanoma News and Research

Latest Melanoma News and Research

Fewer young men in Canada are being diagnosed with cancer

...while the number for young women is stable, according to the Cancer in Young Adults in Canada report released today by Cancer Care Ontario in collaboration with the Public Health Agency of Canada.

12 Sep 2006

Fewer deaths from cancer in the U.S.

According to a new report fewer Americans are dying of cancer even though the rates of new cancers remains the same.

7 Sep 2006

New method for attaching tumor-targeting antibodies to the surface of buckyballs

Hollow buckyballs, spherical molecules made of sixty carbon atoms linked to one another like the panels of a soccer ball, have the potential to ferry large doses of anticancer drugs or imaging agents to tumors.

5 Sep 2006

New method of gene therapy alters immune cells for treatment of advanced melanoma

A team of researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, has demonstrated sustained regression of advanced melanoma in a study of 17 patients by genetically engineering patients' own white blood cells to recognize and attack cancer cells.

4 Sep 2006

Scientists create tumour zapping T cells which knock out cancer

Scientists in the United States have genetically engineered normal immune cells to become specialized fighters and used them to attack cancerous tumours.

31 Aug 2006

New blood test picks up early breast cancer

A new blood test has been developed by an international team of scientists which can detect the very early stage of breast cancer.

7 Aug 2006

Aggressive melanoma cells secrete Nodal - protein critical to embryo formation

A Northwestern University research group has discovered that aggressive melanoma cells secrete Nodal, a protein that is critical to proper embryo formation.

6 Aug 2006

Turning the immune system against cancer

Medicine can now prevent a host of diseases with a mere shot of vaccine. Polio and smallpox are almost non-existent, and mumps and chicken pox are rarely seen nowadays.

4 Aug 2006

Mad dogs and Englishmen should stay out of the midday sun!

In a timely release, as much of Europe and Britain in particular sizzles through an unusually hot summer, a new report is warning against the dangers of exposure to the sun.

30 Jul 2006

How does the immune system isolate and destroy intruders?

Dendritic cells are the body's "watchdogs". They recognize and then degrade pathogens, isolating characteristic fragments that are recognized by the immune system thus triggering targeted responses.

25 Jul 2006

Breakdown of disease caused by UV radiation

Ultraviolet radiation from the sun causes a considerable global disease burden, including specific cancers, a new World Health Organization (WHO) report finds.

25 Jul 2006

Nexavar approved in Europe for treatment of advanced kidney cancer

Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc have announced that the European Commission has granted marketing authorization to Nexavar (sorafenib) tablets for the treatment of patients with advanced renal cell carcinoma.

24 Jul 2006

Doctors may be over-diagnosing melanoma in sun-damaged skin

A Mayo Clinic physician and colleagues have defined the normal number of melanocytes that are present in Caucasians' sun-exposed skin.

18 Jul 2006

A randomized trial to improve early detection and prevention practices among siblings of melanoma patients

An intensive educational intervention targeting siblings of recently diagnosed melanoma patients leads to sustained improvements in the rate of self skin-examination, according to a new study.

10 Jul 2006

New Australian 'assassin' drug has huge potential

Australian researchers have come up with a new drug which they believe has the potential to fight a wide range of illnesses and diseases including cancer, age-related blindness, heart disease and arthritis.

5 Jul 2006

New class of experimental drug that targets master regulator gene called c-Jun

University of New South Wales (UNSW) researchers have announced they are developing a new class of experimental drug that has the potential to treat a diverse range of health problems, from inflammation and cancer through to eye and heart disease.

3 Jul 2006

Buckyballs deliver multiple drugs simultaneously to tumors

Combining a monoclonal antibody known to target melanoma tumors with multiple C60 buckyballs, researchers at Rice University and the University of Texas M. D. Anderson Cancer Center have developed a new way to deliver multiple drugs simultaneously to tumors.

3 Jul 2006